75 related articles for article (PubMed ID: 11929788)
21. Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.
Khan AS; Hojjat-Farsangi M; Daneshmanesh AH; Hansson L; Kokhaei P; Österborg A; Mellstedt H; Moshfegh A
Tumour Biol; 2016 Sep; 37(9):11947-11957. PubMed ID: 27086035
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemia therapy: new targeted therapies on the way.
Vitale C; Burger JA
Expert Opin Pharmacother; 2016 Jun; 17(8):1077-89. PubMed ID: 26988407
[TBL] [Abstract][Full Text] [Related]
23. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia.
Bresin A; D'Abundo L; Narducci MG; Fiorenza MT; Croce CM; Negrini M; Russo G
Cell Death Dis; 2016 Jan; 7(1):e2071. PubMed ID: 26821067
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
25. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.
Bresin A; Callegari E; D'Abundo L; Cattani C; Bassi C; Zagatti B; Narducci MG; Caprini E; Pekarsky Y; Croce CM; Sabbioni S; Russo G; Negrini M
Oncotarget; 2015 Aug; 6(23):19807-18. PubMed ID: 26090867
[TBL] [Abstract][Full Text] [Related]
26. Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practice.
Sanford DS; Wierda WG; Burger JA; Keating MJ; O'Brien SM
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):385-91. PubMed ID: 25817936
[TBL] [Abstract][Full Text] [Related]
27. Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.
Porakishvili N; Vispute K; Steele AJ; Rajakaruna N; Kulikova N; Tsertsvadze T; Nathwani A; Damle RN; Clark EA; Rai KR; Chiorazzi N; Lydyard PM
Mol Med; 2015 Apr; 21(1):46-57. PubMed ID: 25611435
[TBL] [Abstract][Full Text] [Related]
28. Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL.
Iacovelli S; Hug E; Bennardo S; Duehren-von Minden M; Gobessi S; Rinaldi A; Suljagic M; Bilbao D; Bolasco G; Eckl-Dorna J; Niederberger V; Autore F; Sica S; Laurenti L; Wang H; Cornall RJ; Clarke SH; Croce CM; Bertoni F; Jumaa H; Efremov DG
Blood; 2015 Mar; 125(10):1578-88. PubMed ID: 25564405
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C in cellular transformation: a valid target for therapy?
Tarafdar A; Michie AM
Biochem Soc Trans; 2014 Dec; 42(6):1556-62. PubMed ID: 25399570
[TBL] [Abstract][Full Text] [Related]
30. Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).
Woyach JA; Bojnik E; Ruppert AS; Stefanovski MR; Goettl VM; Smucker KA; Smith LL; Dubovsky JA; Towns WH; MacMurray J; Harrington BK; Davis ME; Gobessi S; Laurenti L; Chang BY; Buggy JJ; Efremov DG; Byrd JC; Johnson AJ
Blood; 2014 Feb; 123(8):1207-13. PubMed ID: 24311722
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.
Kazi JU; Kabir NN; Rönnstrand L
Med Oncol; 2013 Dec; 30(4):757. PubMed ID: 24174318
[TBL] [Abstract][Full Text] [Related]
32. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis induction of human prostate carcinoma DU145 cells by diallyl disulfide via modulation of JNK and PI3K/AKT signaling pathways.
Shin DY; Kim GY; Lee JH; Choi BT; Yoo YH; Choi YH
Int J Mol Sci; 2012 Nov; 13(11):14158-71. PubMed ID: 23203057
[TBL] [Abstract][Full Text] [Related]
34. Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL.
Efremov DG; Wiestner A; Laurenti L
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012067. PubMed ID: 23170196
[TBL] [Abstract][Full Text] [Related]
35. The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.
Pauls SD; Lafarge ST; Landego I; Zhang T; Marshall AJ
Front Immunol; 2012; 3():224. PubMed ID: 22908014
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.
Rubio-Patiño C; Palmeri CM; Pérez-Perarnau A; Cosialls AM; Moncunill-Massaguer C; González-Gironès DM; Pons-Hernández L; López JM; Ventura F; Gil J; Pons G; Iglesias-Serret D
Mol Endocrinol; 2012 Sep; 26(9):1508-20. PubMed ID: 22771494
[TBL] [Abstract][Full Text] [Related]
37. The B-cell receptor signaling pathway as a therapeutic target in CLL.
Woyach JA; Johnson AJ; Byrd JC
Blood; 2012 Aug; 120(6):1175-84. PubMed ID: 22715122
[TBL] [Abstract][Full Text] [Related]
38. The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets.
de Paula Careta F; Gobessi S; Panepucci RA; Bojnik E; Morato de Oliveira F; Mazza Matos D; Falcão RP; Laurenti L; Zago MA; Efremov DG
Haematologica; 2012 Aug; 97(8):1246-54. PubMed ID: 22331265
[TBL] [Abstract][Full Text] [Related]
39. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons.
Zhang L; Blackman BE; Schonemann MD; Zogovic-Kapsalis T; Pan X; Tagliaferri M; Harris HA; Cohen I; Pera RA; Mellon SH; Weiner RI; Leitman DC
PLoS One; 2010 Jul; 5(7):e11791. PubMed ID: 20668547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
